Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 151 - 190 av 190 resultater
Tid
Selskap
Tittel
Sektor
Kategori
20 Oct 2022
11:31 CEST
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 09/2022
20103015 Pharmaceuticals
Corporate life
18 Oct 2022
17:45 CEST
VIRBAC
VIRBAC: Revenue growth at end of September at +7.7% at comparable exchange rates and perimeter (+12.7% at actual rates
20103015 Pharmaceuticals
Sales
18 Oct 2022
17:45 CEST
VIRBAC
VIRBAC: Croissance du chiffre d’affaires à fin septembre à +7,7% à taux de change et périmètre comparables (+12,7% à taux réels)
20103015 Pharmaceuticals
Sales
15 Sep 2022
17:45 CEST
VIRBAC
Virbac : Communiqué de mise à disposition du rapport financier semestriel au 30 juin 2022.
20103015 Pharmaceuticals
Other subject
15 Sep 2022
17:45 CEST
VIRBAC
Virbac: increase in operating income in the first half of 2022 reflecting the dynamism of our business
20103015 Pharmaceuticals
Sales
15 Sep 2022
17:45 CEST
VIRBAC
Virbac : Public release of the Half-Year Financial Report at 30 June 2022.
20103015 Pharmaceuticals
Other subject
15 Sep 2022
17:45 CEST
VIRBAC
Virbac: résultat opérationnel du premier semestre 2022 en croissance qui reflète le dynamisme de notre activité
20103015 Pharmaceuticals
Sales
12 Sep 2022
10:29 CEST
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 08/2022
20103015 Pharmaceuticals
Corporate life
12 Sep 2022
10:29 CEST
VIRBAC
Virbac : Declaration of the number of shares and voting rights 08/2022
20103015 Pharmaceuticals
Corporate life
12 Sep 2022
10:22 CEST
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 07/2022
20103015 Pharmaceuticals
Corporate life
12 Sep 2022
10:22 CEST
VIRBAC
Virbac : Declaration of the number of shares and voting rights 07/2022
20103015 Pharmaceuticals
Corporate life
19 Jul 2022
17:45 CEST
VIRBAC
VIRBAC: croissance du chiffre d’affaires au premier semestre 2022 de +12,0% à taux de change comparables (+16,4% à taux réels), portée par de bonnes performances dans toutes les zones
20103015 Pharmaceuticals
Sales
19 Jul 2022
17:45 CEST
VIRBAC
VIRBAC: growth in revenue in the first half of 2022 of +12.0% at comparable exchange rates (+16.4% at real rates), driven by good performance in all areas
20103015 Pharmaceuticals
Sales
08 Jul 2022
15:23 CEST
VIRBAC
Virbac: bilan semestriel du contrat de liquidité au 30 juin 2022
20103015 Pharmaceuticals
Other subject
07 Jul 2022
18:42 CEST
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 06/2022
20103015 Pharmaceuticals
Corporate life
07 Jul 2022
18:42 CEST
VIRBAC
Virbac : Declaration of the number of shares and voting rights June 2022
20103015 Pharmaceuticals
Corporate life
03 Jun 2022
17:22 CEST
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 05/2022
20103015 Pharmaceuticals
Corporate life
03 Jun 2022
17:22 CEST
VIRBAC
Virbac : Declaration of the number of shares and voting rights 05/2022
20103015 Pharmaceuticals
Corporate life
30 May 2022
15:54 CEST
VIRBAC
Virbac: communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale ordinaire
20103015 Pharmaceuticals
-
06 May 2022
10:41 CEST
VIRBAC
Virbac : Declaration of the number of shares and voting rights 04/2022
20103015 Pharmaceuticals
Corporate life
06 May 2022
10:41 CEST
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 04/2022
20103015 Pharmaceuticals
Corporate life
28 Apr 2022
16:26 CEST
VIRBAC
Communiqué de mise à disposition du rapport financier annuel au 31 décembre 2021
20103015 Pharmaceuticals
Other subject
28 Apr 2022
16:26 CEST
VIRBAC
Release of the annual financial report as of December 31, 2021
20103015 Pharmaceuticals
Other subject
14 Apr 2022
18:02 CEST
VIRBAC
Virbac : Très forte croissance du chiffre d’affaires au premier trimestre 2022 de +16,2% à taux de change comparables (+19,3% à taux réels), portée par de bonnes performances dans toutes les zones
20103015 Pharmaceuticals
Sales
14 Apr 2022
18:02 CEST
VIRBAC
Virbac : Very strong growth in revenue in the first quarter of 2022 of +16.2% at comparable exchange rates (+19.3% at real rates), driven by good performance in all areas
20103015 Pharmaceuticals
Sales
04 Apr 2022
10:48 CEST
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 03/2022
20103015 Pharmaceuticals
Corporate life
04 Apr 2022
10:48 CEST
VIRBAC
Virbac : Declaration of the number of shares and voting rights 03/2022
20103015 Pharmaceuticals
Corporate life
22 Mar 2022
17:45 CET
VIRBAC
VIRBAC: Résultat opérationnel courant 2021 en très forte croissance qui reflète l’excellent dynamisme de notre activité dans un marché en forte progression
20103015 Pharmaceuticals
Sales
22 Mar 2022
17:45 CET
VIRBAC
VIRBAC: 2021 operating profit from ordinary activities showed very strong growth, reflecting the excellent dynamism of our business in a rapidly growing market
20103015 Pharmaceuticals
Sales
01 Mar 2022
17:24 CET
VIRBAC
Virbac : Declaration of the number of shares and voting rights 02/2022
20103015 Pharmaceuticals
Corporate life
01 Mar 2022
17:24 CET
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 02/2022
20103015 Pharmaceuticals
Corporate life
28 Feb 2022
18:26 CET
VIRBAC
Virbac : Declaration of the number of shares and voting rights 01/2022
20103015 Pharmaceuticals
Corporate life
28 Feb 2022
18:26 CET
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 01/2022
20103015 Pharmaceuticals
Corporate life
19 Jan 2022
17:45 CET
VIRBAC
VIRBAC: Exceptional growth in annual revenue of +18.4% at comparable exchange rates and scope (+14.9% at constant rates and real scope), driven by remarkable performance in a very buoyant market
20103015 Pharmaceuticals
Sales
19 Jan 2022
17:45 CET
VIRBAC
VIRBAC: Exceptionnelle croissance du chiffre d’affaires annuel de +18,4% à taux de change et périmètre comparables (+14,9% à taux constants et périmètre réel), portée par une performance remarquable dans un marché très porteur
20103015 Pharmaceuticals
Sales
12 Jan 2022
15:48 CET
VIRBAC
Virbac: bilan semestriel du contrat de liquidité au 31 décembre 2021
20103015 Pharmaceuticals
Other subject
07 Jan 2022
12:02 CET
VIRBAC
Virbac : Declaration of the number of shares and voting rights 12/2021
20103015 Pharmaceuticals
Corporate life
07 Jan 2022
12:02 CET
VIRBAC
Virbac : Déclaration d'actions et de droits de vote 12/2021
20103015 Pharmaceuticals
Corporate life
06 Dec 2021
11:53 CET
VIRBAC
Virbac : Declaration of the number of shares and voting rights November 2021
20103015 Pharmaceuticals
Corporate life
06 Dec 2021
11:53 CET
VIRBAC
Virbac : Déclaration d'actions et de droits de vote Novembre 2021
20103015 Pharmaceuticals
Corporate life
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
2
3
4
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Stock options
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva